Metastatic Solid Cancers Clinical Trials
0 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 1
Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer
Metastatic Solid Cancers
National Cancer Institute (NCI)210 enrolled1 locationNCT06253520
Recruiting
Phase 2
Intestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Malignant Solid Tumors
Drug ResistanceMetastatic Solid CancersRadiotherapy+3 more
Chuangzhen Chen48 enrolled1 locationNCT07071103